Co-Chairs: Raymond T. Chung, MD Robert S. Klein, MD John F. Reinus, MD, FACG David L. Thomas, MD, MPH Faculty: Arthur Y. Kim, MD, FIDSA Jennifer J. Kiser, PharmD Alain H. Litwin, MD, MPH Kristen M. Marks, MD Jorge A. Marrero, MD Paul Martin, MD Andrew J. Muir, MD, MHS Susanna Naggie, MD, MHS Marion G. Peters, MD Stuart C. Ray, MD, FIDSA Kenneth E. Sherman, MD, PhD Mark S. Sulkowski, MD John B. Wong, MD 4th Annual CME Symposium This advanced continuing medical education activity will provide participants with state-of-the-art education and practical guidance from internationally recognized experts on hepatitis C virus infection. Key Learning Objectives PHYSICIANS CME ISSUED BY •Recognize the indications for treatment of HCV infection as well as areas of uncertainty in treatment •Explain barriers to effective care of patients with hepatitis C •Distinguish the recognition and treatment of acute HCV infection from that of chronic infection •Apply new information to manage disease in difficult-to-treat populations •Indicate new therapeutic drugs, pharmacology of HCV therapy, and resistance to treatments •Demonstrate the approach to diagnosis and treatment of hepatocellular carcinoma ALBERT EINSTEIN COLLEGE OF MEDICINE OF YESHIVA UNIVERSITY Albert Einstein College of Medicine of Yeshiva Target Audience University is accredited by the Accreditation This activity is designed for hepatologists, gastroenterologists, infectious disease specialists, nurse practitioners, and other frontline allied healthcare professionals involved in management of patients with hepatitis C and HCV/HIV coinfection. Council for Continuing Medical Education to provide continuing medical education for physicians. Albert Einstein College of Medicine designates this live educational activity for Registration & Fees a maximum of 10.25 AMA PRA Category 1 HEP Registration by 12/31/14............................................................................... $295 AECOM & Residents/Fellows............................................................................. $245 SAVE — Register for both HEPATITIS C MANAGEMENT - STATE OF THE ART & HIV Management 2015: THE NEW YORK COURSE by 12/31/14......................................$595 For more information or to register, visit 10.25 CME credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity. This activity was planned and produced in accordance with the Requirements of the ACCME. www.hep2015.com or call 888-391-3996